Showing results (1-10 of 121) with videos related to
Sort By:
Pageof 13
Current Opinion in Oncology|June 10, 2004
Monoclonal antibodies against vascular endothelial growth factor and epidermal growth factor receptor in advanced colorectal cancers: present and future directionsNaureen Starling, David CunninghamBritish Journal of Cancer|February 16, 2023
Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer: S Pyrhönen, T Kuitunen, P Nyandoto & M KouriNaureen Starling, David CunninghamCurrent Oncology Reports|April 26, 2005
Second-line therapy for advanced colorectal carcinomaNaureen Starling, David CunninghamClinical Colorectal Cancer|May 6, 2005
Cetuximab in previously treated colorectal cancerNaureen Starling, David CunninghamOncotargets and Therapy|December 10, 2016
Trastuzumab in the management of gastroesophageal cancer: patient selection and perspectivesMichael Davidson, Naureen StarlingTherapeutic Advances in Medical Oncology|March 28, 2017
Liposomal irinotecan in gemcitabine-refractory metastatic pancreatic cancer: efficacy, safety and place in therapyEmma Kipps, Kate Young, Naureen StarlingTherapeutics and Clinical Risk Management|March 25, 2008
Role of erlotinib in the management of pancreatic cancerNaureen Starling, John Neoptolemos, David CunninghamSeminars in Cancer Biology|October 3, 2019
The molecular biology of pancreatic neuroendocrine neoplasms: Challenges and translational opportunitiesKate Young, Naureen Starling, Anguraj SadanandamCurrent Treatment Options in Oncology|August 18, 2022
Neoadjuvant and Adjuvant Therapy Approaches to Gastric CancerCaroline Fong, Edwina Johnston, Naureen StarlingCurrent Cancer Drug Targets|August 20, 2010
Predictive molecular markers of response to epidermal growth factor receptor(EGFR) family-targeted therapiesSarah Barton, Naureen Starling, Charles SwantonPageof 13